Research
Hormonal
Tirzepatide offers superior glycemic control and weight reduction compared to conventional GLP-1 receptor agonists.
Practitioners may consider Tirzepatide as a more effective option for managing glycemic control and weight in patients with T2DM.
StrongSupportsmedium confidence
It offers superior glycemic control and weight reduction compared to conventional GLP-1 receptor agonists.
Why this rating
Based on clinical trials mentioned in the abstract.
Source
Tirzepatide: A dual action approach to weight reduction and glycemic control in type 2 diabetes mellitus
Princy Domnic Dsouza et al. · MGM Journal of Medical Sciences · 2025
otherCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →